Immediate Impact
2 standout
Citing Papers
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
2024 Standout
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
2022 Standout
Works of Tsung-Ling Lee being referenced
Regulating the stem cell industry: needs and responsibilities
2017
The deadly business of an unregulated global stem cell industry
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tsung-Ling Lee | 70 | 19 | 56 | 56 | 22 | 199 | |
| Tina Rulli | 42 | 16 | 27 | 47 | 15 | 162 | |
| Tianyu Wang | 29 | 37 | 14 | 50 | 37 | 274 | |
| Andrew W. Siegel | 89 | 7 | 72 | 13 | 21 | 197 | |
| Daniel J. Minter | 69 | 13 | 10 | 28 | 21 | 255 | |
| Rose Geransar | 59 | 18 | 51 | 7 | 16 | 287 | |
| Julianna Shinnick | 77 | 14 | 24 | 7 | 14 | 283 | |
| Kathleen Valverde | 45 | 23 | 23 | 13 | 20 | 263 | |
| Veronica Fitzpatrick | 31 | 8 | 11 | 13 | 27 | 298 | |
| Parris Diaz | 15 | 25 | 13 | 17 | 21 | 242 | |
| Mette Ebbesen | 43 | 23 | 33 | 47 | 24 | 274 |
All Works
Login with ORCID to disown or claim papers
Loading papers...